Universal Beteiligungs und Servicegesellschaft mbH reduced its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 31.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 52,150 shares of the company's stock after selling 23,984 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.07% of DaVita worth $7,977,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of DVA. Wealth Quarterback LLC bought a new position in DaVita in the 1st quarter valued at about $765,000. AustralianSuper Pty Ltd acquired a new position in shares of DaVita in the first quarter worth approximately $10,763,000. Impact Partnership Wealth LLC grew its stake in DaVita by 21.7% during the first quarter. Impact Partnership Wealth LLC now owns 2,363 shares of the company's stock worth $361,000 after purchasing an additional 422 shares during the period. Victory Capital Management Inc. raised its position in shares of DaVita by 31.9% during the first quarter. Victory Capital Management Inc. now owns 57,074 shares of the company's stock worth $8,731,000 after purchasing an additional 13,802 shares during the period. Finally, Kesler Norman & Wride LLC boosted its position in shares of DaVita by 15.8% during the first quarter. Kesler Norman & Wride LLC now owns 5,643 shares of the company's stock valued at $864,000 after buying an additional 769 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.
DaVita Stock Up 0.1%
Shares of NYSE:DVA traded up $0.20 during trading hours on Monday, hitting $145.37. The company's stock had a trading volume of 440,209 shares, compared to its average volume of 857,409. The company has a market capitalization of $10.98 billion, a price-to-earnings ratio of 14.41, a P/E/G ratio of 1.00 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. DaVita Inc. has a 52 week low of $131.76 and a 52 week high of $179.60. The firm's fifty day moving average price is $140.31 and its 200 day moving average price is $148.29.
DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same quarter last year, the business posted $2.26 EPS. The firm's quarterly revenue was up 5.0% on a year-over-year basis. As a group, research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.
Analysts Set New Price Targets
DVA has been the subject of several recent analyst reports. Truist Financial cut their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $167.40.
View Our Latest Analysis on DVA
Insider Transactions at DaVita
In other DaVita news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company's stock.
About DaVita
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading

Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.